BridgeMD
New treatment option for Hypophosphatemia
Official title Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of Hypophosphatemia.
ClinicalTrials.gov ID: NCT07233889
What this study is testing
What is Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules?
Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for hypophosphatemia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this clinical trial is to evaluate the efficacy and safety of Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the treatment of participants with mild, moderate, and severe hypophosphatemia. The main questions it aims to answer are: Does enteral supplementation of Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules elevate participants' serum phosphorus?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Aged 18-80 years (inclusive), regardless of gender;
- ICU inpatients with a serum phosphate concentration \<0.80 mmol/L, and for whom the clinician determines phosphate supplementation is required;
- Ability to receive enteral nutrition, with a daily enteral caloric intake ≥10 kcal/kg/day;
- The subject or their legal guardian fully understands the purpose and significance of this trial, voluntarily agrees to participate, provides written...
You likely can't join if
- Pregnant and lactating women;
- Patients with contraindications for enteral administration, such as acute upper gastrointestinal bleeding, mechanical intestinal obstruction, severe...
- Expected ICU stay ≤96 hours;
- Known allergy to any component of the investigational drug or drugs with a similar chemical structure;
- Severe renal impairment: estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73m²;
- people with hyperthyroidism requiring clinical intervention;
See the full eligibility criteria
- Aged 18-80 years (inclusive), regardless of gender;
- ICU inpatients with a serum phosphate concentration \<0.80 mmol/L, and for whom the clinician determines phosphate supplementation is required;
- Ability to receive enteral nutrition, with a daily enteral caloric intake ≥10 kcal/kg/day;
- The subject or their legal guardian fully understands the purpose and significance of this trial, voluntarily agrees to participate, provides written informed consent, and is willing to strictly adhere to the clinical...
- Pregnant and lactating women;
- Patients with contraindications for enteral administration, such as acute upper gastrointestinal bleeding, mechanical intestinal obstruction, severe acute pancreatitis, digestive tract fistula, gastrointestinal...
- Expected ICU stay ≤96 hours;
- Known allergy to any component of the investigational drug or drugs with a similar chemical structure;
- Severe renal impairment: estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73m²;
- people with hyperthyroidism requiring clinical intervention;
- people requiring sodium restriction;
- Other conditions deemed by the investigator as unsuitable for inclusion.
The study team makes the final eligibility decision.
Where it's taking place
- Wuhan, Hubei, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.